Goldman Sachs
TRAW icon

Goldman Sachs’s Traws Pharma TRAW Stock Holding History

Goldman Sachs’s Portfolio TRAW Stock Details TRAW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-596
Closed -$57K – 6743
2021
Q3 		$57K Buy
+596
New +$76.8K ﹤0.01% 6019
2016
Q2 		– Hold
0
– -$13K – 7286
2016
Q1 		– Hold
0
– – – 6853
2015
Q4 		– Hold
0
– – – 6882
2015
Q3 		– Hold
0
– – – 6935
2015
Q2 		– Sell
-1
Closed -$143K – 6813
2015
Q1 		$76K Buy
+1
New +$164K ﹤0.01% 6547
2014
Q4 		– Hold
0
– – – 6646
2014
Q3 		– Sell
-1
Closed -$285K – 6565
2014
Q2 		$366K Buy
+1
New +$295K ﹤0.01% 5600

Other funds holding TRAW

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Anson Funds Management
Anson Funds Management Dallas, Texas $1.68B AUM 373.57% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Hudson Bay Capital Management
Hudson Bay Capital Management Stamford, Connecticut $36.8B AUM 42.13% 1-Year Est. Return
Susquehanna Fundamental Investments
Susquehanna Fundamental Investments Bala Cynwyd, Pennsylvania $5.32B AUM 30.24% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
GSA Capital Partners
GSA Capital Partners London, United Kingdom $1.59B AUM 39.8% 1-Year Est. Return

Goldman Sachs's TRAW Position: Q4 2021 in Review

Goldman Sachs sold out of Traws Pharma (TRAW) in Q4 2021, closing a stake of 596 shares — an estimated $57K sold.

Goldman Sachs first reported a position in TRAW in Q2 2014 and held it in 3 quarters. The position peaked at $366K in Q2 2014. 34 funds tracked by Wall St. Rank hold TRAW as of Q4 2021.

  • Goldman Sachs reported no remaining Traws Pharma position as of Q4 2021 after selling out during the quarter.
  • Goldman Sachs sold 596 Traws Pharma shares in Q4 2021, an estimated $57K.
  • Goldman Sachs first reported a position in Traws Pharma in Q2 2014 and held it in 3 quarters.
  • Goldman Sachs's Traws Pharma position peaked at $366K in Q2 2014.
  • 34 funds tracked by Wall St. Rank held Traws Pharma as of Q4 2021.

Based on Goldman Sachs's 13F filing for Q4 2021, filed 14 Feb 2022.